Caricamento...
Safety and Immunologic Response of a Viral Vaccine to PSA in Combination with Radiation Therapy when Metronomic-Dose IL-2 Is Used as an Adjuvant
PURPOSE: We have previously reported on the safety and immunological response of a poxvirus-based vaccine encoding PSA used in combination with radiation therapy in patients with localized prostate cancer. We hypothesized that a “metronomic” dose of IL-2 as a biologic adjuvant would cause less toxic...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2639763/ https://ncbi.nlm.nih.gov/pubmed/18698048 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-5162 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|